Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis


WINTHROP K. L. , PARK S., Gül A. , CARDIEL M. H. , GOMEZ-REINO J. J. , TANAKA Y., ...More

ANNALS OF THE RHEUMATIC DISEASES, vol.75, no.6, pp.1133-1138, 2016 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 75 Issue: 6
  • Publication Date: 2016
  • Doi Number: 10.1136/annrheumdis-2015-207319
  • Title of Journal : ANNALS OF THE RHEUMATIC DISEASES
  • Page Numbers: pp.1133-1138

Abstract

Objectives To evaluate the risk of opportunistic infections (OIs) in patients with rheumatoid arthritis (RA) treated with tofacitinib.